Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock
- PMID: 10768085
- DOI: 10.1016/s0749-0704(05)70113-5
Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock
Abstract
Organ system dysfunction is a common adverse sequelae of severe sepsis and septic shock and has been reported to be the most common cause of death in the noncoronary intensive care unit. The pathophysiology of the development of multiple organ system dysfunction is likely multifactoral and may take several different pathways. The frequency of specific organ system involvement is dependent on the definition used to describe the organ dysfunction. The presence of organ dysfunction has great clinical impact on the underlying disease process, can prolong the hospital stay, increase the cost of care, and has been associated with an increase in mortality rate. At present, there is no recognized specific treatment for established organ failure, this primary attention has been directed toward prevention.
Similar articles
-
Increased Neutrophil Gelatinase-Associated Lipocalin is Associated with Mortality and Multiple Organ Dysfunction Syndrome in Severe Sepsis and Septic Shock.Shock. 2015 Sep;44(3):234-8. doi: 10.1097/SHK.0000000000000408. Shock. 2015. PMID: 26009825
-
[The heart in infection and MODS (multiple organ dysfunction syndrome)].Wien Klin Wochenschr. 1997;109 Suppl 1:3-24. Wien Klin Wochenschr. 1997. PMID: 9173672 Review. German.
-
Sepsis and septic shock.Emerg Med Clin North Am. 1986 Nov;4(4):809-40. Emerg Med Clin North Am. 1986. PMID: 3536440 Review.
-
Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy.Acta Clin Belg. 2010 Sep-Oct;65(5):323-9. doi: 10.1179/acb.2010.070. Acta Clin Belg. 2010. PMID: 21128559 Review.
-
Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study.Eur J Anaesthesiol. 2015 Mar;32(3):189-98. doi: 10.1097/EJA.0000000000000126. Eur J Anaesthesiol. 2015. PMID: 25032942 Clinical Trial.
Cited by
-
Near-infrared spectroscopy StO2 monitoring to assess the therapeutic effect of drotrecogin alfa (activated) on microcirculation in patients with severe sepsis or septic shock.Ann Intensive Care. 2013 Sep 4;3(1):30. doi: 10.1186/2110-5820-3-30. Ann Intensive Care. 2013. PMID: 24007807 Free PMC article.
-
Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.Croat Med J. 2006 Jun;47(3):385-97. Croat Med J. 2006. PMID: 16758516 Free PMC article.
-
Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections.Clin Diagn Lab Immunol. 2004 Jan;11(1):161-7. doi: 10.1128/cdli.11.1.161-167.2004. Clin Diagn Lab Immunol. 2004. PMID: 14715564 Free PMC article.
-
Prolonged non-survival in PICU: does a do-not-attempt-resuscitation order matter.BMC Anesthesiol. 2013 Nov 17;13(1):43. doi: 10.1186/1471-2253-13-43. BMC Anesthesiol. 2013. PMID: 24237685 Free PMC article.
-
Nitric Oxide Does Not Improve Liver Mitochondrial Function 48 Hours After Cecal Ligation and Perforation in Experimental Sepsis.Antioxidants (Basel). 2025 Jul 16;14(7):868. doi: 10.3390/antiox14070868. Antioxidants (Basel). 2025. PMID: 40722972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical